Want to see MITUY full AI Analyst Report?
Top Page
Mitsui Chemicals
(OTC:MITUY)
Select Model
Select Model
Rating:66Neutral
Price Target:
$15.00
▲(13.12% Upside)
Action:Reiterated
Date:08/10/26
The score is anchored by steady-but-not-top-tier financial performance: improving operating margins and positive free cash flow are offset by thin/volatile net margins, meaningful leverage (debt-to-equity ~0.94), and pressured/uneven cash generation. Technicals are supportive with price above key moving averages and positive MACD, while valuation is reasonable (P/E ~12.3) with a solid dividend yield (~3.2%), adding to the overall attractiveness.
Positive Factors
Diversified specialty materials portfolio
Exposure to multiple end markets reduces dependence on any single customer or application. The mix of specialty, electronics, mobility, and healthcare materials can support more resilient demand and create opportunities for long-term product qualification.
Negative Factors
Meaningful leverage limits flexibility
Debt is close to shareholders' equity, leaving less flexibility if chemical demand, pricing, or operating rates weaken. Higher leverage can also constrain investment capacity and increase the importance of maintaining stable cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified specialty materials portfolio
Exposure to multiple end markets reduces dependence on any single customer or application. The mix of specialty, electronics, mobility, and healthcare materials can support more resilient demand and create opportunities for long-term product qualification.
Read all positive factors
Mitsui Chemicals (MITUY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.44B
Dividend Yield3.37%
Average Volume (3M)0.00
Price to Earnings (P/E)11.7
Beta (1Y)0.67
Revenue Growth-6.50%
EPS Growth333.40%
CountryUS
Employees16,967
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)181.50
Shares Outstanding401,687,620
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.34
Price to Book (P/B)0.81
Price to Sales (P/S)0.40
P/FCF Ratio7.81
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mitsui Chemicals Business Overview & Revenue Model
Company Description
Mitsui Chemicals, Inc. is a global chemical company with diverse operations spanning several key sectors, including mobility, healthcare, food and packaging, and fundamental chemical materials. The company's Mobility division focuses on developing...
How the Company Makes Money
Mitsui Chemicals primarily makes money by manufacturing chemical and materials products and selling them to business customers (B2B) under supply contracts and ongoing customer relationships. Revenue is generated across multiple product groups, ty...
Mitsui Chemicals Earnings Call Summary
Earnings Call Date:Feb 04, 2025
(Q3-2024)
| % Change Since: |
Next Earnings Date:Nov 11, 2026
Earnings Call Sentiment Negative
The earnings call highlighted growth in the Mobility Solutions segment and strong cash flow improvements, but these were overshadowed by significant declines in overall revenue, particularly in Basic & Green Materials, and continuing challenges in the semiconductor and smartphone markets. The forecast was also downgraded, indicating ongoing difficulties.Positive Updates
Mobility Solutions Growth
Operating income before special items for the Mobility Solutions segment increased by JPY 2.1 billion year-over-year to JPY 41.0 billion, mainly due to growth in solar cell encapsulant materials and recovery in automotive applications.
Negative Updates
Overall Revenue Decline
Sales revenue for the April to December period was JPY 1.2745 trillion, a decrease of JPY 154.4 billion versus the same period last year. Operating income before special items decreased by JPY 37.9 billion.
Read all updates
Q3-2024 Updates
Positive
Negative
Mobility Solutions Growth
Operating income before special items for the Mobility Solutions segment increased by JPY 2.1 billion year-over-year to JPY 41.0 billion, mainly due to growth in solar cell encapsulant materials and recovery in automotive applications.
Read all positive updates
Company Guidance
During the Mitsui Chemicals earnings call for the third quarter of fiscal year 2023, CFO Nakajima provided guidance indicating a challenging period due to sluggish demand in key markets and falling raw material prices, leading to a year-over-year decline in sales and profits. The company revised its full-year forecast for operating income before special items from JPY 112.0 billion to JPY 93.0 billion, and net income was adjusted downward to JPY 50.0 billion, partly due to restructuring losses. Despite these challenges, the annual dividend remains projected at JPY 140 per share. Significant declines in semiconductor and smartphone markets impacted the ICT solutions segment, while the Life & Healthcare segment struggled with inventory adjustments. Mobility Solutions showed resilience with a forecasted operating income increase to JPY 57.0 billion, driven by growth in solar cell materials and automotive recovery. Overall, Mitsui Chemicals anticipates a JPY 20.9 billion decrease in profit for the year, with free cash flows expected to be positive at JPY 24.0 billion.Mitsui Chemicals Financial Statement Overview
Summary
Income Statement
67
Positive
Balance Sheet
62
Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.74T | 1.77T | 1.81T | 1.75T | 1.88T | 1.61T |
| Gross Profit | 409.93B | 403.46B | 388.29B | 370.80B | 381.49B | 378.74B |
| EBITDA | 221.83B | 202.22B | 186.12B | 183.24B | 182.81B | 216.99B |
| Net Income | 66.77B | 36.45B | 32.24B | 50.00B | 82.94B | 109.99B |
Balance Sheet | ||||||
| Total Assets | 2.25T | 2.16T | 2.15T | 2.22T | 2.07T | 1.93T |
| Cash, Cash Equivalents and Short-Term Investments | 216.40B | 183.91B | 209.23B | 249.51B | 262.72B | 224.65B |
| Total Debt | 816.54B | 743.40B | 737.98B | 756.76B | 738.25B | 666.09B |
| Total Liabilities | 1.26T | 1.17T | 1.18T | 1.23T | 1.18T | 1.13T |
| Stockholders Equity | 867.48B | 868.48B | 848.28B | 862.85B | 786.83B | 712.65B |
Cash Flow | ||||||
| Free Cash Flow | 53.75B | 89.86B | 62.09B | 7.35B | -36.62B | -23.63B |
| Operating Cash Flow | 183.28B | 225.83B | 200.50B | 161.34B | 101.24B | 92.58B |
| Investing Cash Flow | -144.05B | -145.41B | -165.01B | -123.94B | -106.34B | -205.23B |
| Financing Cash Flow | -17.04B | -78.00B | -74.44B | -26.02B | 2.54B | 89.22B |
Mitsui Chemicals Technical Analysis
Positive
13.26
Price Trends
13.32
Positive
12.94
Positive
13.02
Positive
Market Momentum
0.19
Negative
57.13
Neutral
59.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MITUY, the sentiment is Positive. The current price of 13.26 is below the 20-day moving average (MA) of 13.57, below the 50-day MA of 13.32, and above the 200-day MA of 13.02, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 57.13 is Neutral, neither overbought nor oversold. The STOCH value of 59.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MITUY.
Mitsui Chemicals Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $5.64B | 35.19 | 12.79% | 0.59% | 10.14% | 16.56% | |
69 Neutral | $4.35B | 23.60 | 12.07% | 2.02% | -4.74% | -53.83% | |
69 Neutral | $3.99B | 23.80 | 7.16% | 2.91% | 2.36% | 42.56% | |
66 Neutral | $5.44B | 11.68 | 7.58% | 3.34% | -6.50% | 333.40% | |
62 Neutral | $7.69B | 53.42 | 1.59% | ― | -1.88% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | $3.22B | 17.84 | 9.16% | 1.71% | -0.57% | 81.10% |
* Basic Materials Sector Average
MITUY
Mitsui Chemicals
13.15
0.89
7.28%
BCPC
Balchem
180.19
19.35
12.03%
CBT
Cabot
85.18
7.83
10.12%
FUL
H.B. Fuller Company
60.85
2.46
4.22%
AVNT
Avient
44.26
9.88
28.74%
SSL
Sasol
12.10
6.14
103.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.